国药控股（01099.HK）：9月15日南向资金增持42.08万股

证券之星2023-09-16

9月15日北向资金增持42.08万股国药控股（01099.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持235.25万股。近20个交易日中，获南向资金增持的有16天，累计净增持947.63万股。截至目前，南向资金持有国药控股（01099.HK）1.37亿股，占公司已发行普通股的10.21%。国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。该公司通过四个部门运营业务。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2367640720?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-09-16 05:11","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2367640720","market":"hk","top_or_hot":-1,"title":"国药控股（01099.HK）：9月15日南向资金增持42.08万股","media":"证券之星","content":"<div>\n<p>9月15日北向资金增持42.08万股国药控股（01099.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持235.25万股。近20个交易日中，获南向资金增持的有16天，累计净增持947.63万股。截至目前，南向资金持有国药控股（01099.HK）1.37亿股，占公司已发行普通股的10.21%。国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。该公司通过四个部门运营业务。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091605120083e7141b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国药控股（01099.HK）：9月15日南向资金增持42.08万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国药控股（01099.HK）：9月15日南向资金增持42.08万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-16 05:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091605120083e7141b&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月15日北向资金增持42.08万股国药控股（01099.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持235.25万股。近20个交易日中，获南向资金增持的有16天，累计净增持947.63万股。截至目前，南向资金持有国药控股（01099.HK）1.37亿股，占公司已发行普通股的10.21%。国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。该公司通过四个部门运营业务。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091605120083e7141b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1115378108.SGD","symbol_name":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091605120083e7141b&s=b","article_id":"2367640720","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091605120083e7141b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2367640720","pubTimestamp":1694812304,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近5个交易日中，获南向资金增持的有4天，累计净增持235.25万股。截至目前，南向资金持有国药控股1.37亿股，占公司已发行普通股的10.21%。国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。医药分销部门向医院、其他分销商、零售药店及诊所等客户分销医药制品。其他业务部门分销实验室用品、制造及分销化学试剂、生产及销售医药制品。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","01099":"国药控股","BK1197":"保健护理产品经销商","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","BK1500":"做空集合股","BK1515":"抗疫概念"},"translate_title":"Sinopharm Holdings (01099. HK): On September 15, Southbound Capital increased its holdings by 420,800 shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"9月15日北向资金增持42.08万股国药控股（01099.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持235.25万股。近20个交易日中，获南向资金增持的有16天，累计净增持947.63万股。截至目前，南向资金持有国药控股（01099.HK）1.37亿股，占公司已发行普通股的10.21%。国药控股股份有限公司是一家主要从事药品及医疗器械分销业务的中国公司。该公司通过四个部门运营业务。医药分销部门向医院、其他分销商、零售药店及诊所等客户分销医药制品。医疗器械业务部门向客户分销医疗器械，并提供安装和维修服务。医药零售业务部门经营医药连锁店。其他业务部门分销实验室用品、制造及分销化学试剂、生产及销售医药制品。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。证券之星力求但不保证该信息（包括但不限于文字、视频、音频、数据及图表）全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2367640720","isCrawlerRequest":true}